Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver changes in patients with hyperthyroidism.

J Sola1, F J Pardo-Mindán, J Zozaya

  • 1Department of Pathology, Clínica Universitaria de Navarra, Faculty of Medicine, Pamplona, Spain.

Liver
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL study.

ESMO open·2025
Same author

Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study.

Cardiovascular and interventional radiology·2025
Same author

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.

ESMO open·2023
Same journal

Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma.

Liver·2002
Same journal

Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.

Liver·2002
Same journal

Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test.

Liver·2002
Same journal

Macro-aspartate aminotransferase in a female with antibodies to hepatitis C virus.

Liver·2002
Same journal

Cytotoxic response of sinusoidal endothelial cells to polymorphonuclear leukocytes and its potential implication in hypoxia-reoxygenation injury.

Liver·2002
Same journal

Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride.

Liver·2002
See all related articles

Hyperthyroidism can cause specific liver changes, including cholestasis and inflammation, observed in hepatic biopsies. These findings highlight the thyroid

Area of Science:

  • Hepatology
  • Endocrinology
  • Pathology

Background:

  • Hyperthyroidism is a condition involving excess thyroid hormones.
  • Thyroid hormones significantly impact metabolic processes, including liver function.
  • Liver involvement in hyperthyroidism is recognized but requires detailed histopathological characterization.

Purpose of the Study:

  • To investigate and characterize the specific histopathological liver changes in patients with hyperthyroidism.
  • To correlate observed liver lesions with clinical findings and explore potential pathophysiological mechanisms.

Main Methods:

  • Analysis of hepatic biopsies from five patients diagnosed with hyperthyroidism.
  • Histopathological examination to identify characteristic cellular and tissue alterations.

Related Experiment Videos

  • Clinical data review for clinicopathological correlation.

    • Main Results:

    • All five patients exhibited a consistent pattern of liver changes.
    • Characteristic findings included mild to moderate intrahepatocytic cholestasis.
    • Other observed features were lobular inflammatory infiltrate with eosinophils and Kupffer cell hyperplasia.

    Conclusions:

    • A distinct histopathological profile of liver lesions is associated with hyperthyroidism.
    • The findings suggest a direct or indirect impact of thyroid hormone excess on hepatic tissue.
    • Further research is warranted to elucidate the precise pathophysiology and clinical significance of these liver changes.